Giuseppe Cancello

3.3k total citations
44 papers, 2.0k citations indexed

About

Giuseppe Cancello is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giuseppe Cancello has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 31 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giuseppe Cancello's work include Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (19 papers) and Cancer Treatment and Pharmacology (15 papers). Giuseppe Cancello is often cited by papers focused on Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (19 papers) and Cancer Treatment and Pharmacology (15 papers). Giuseppe Cancello collaborates with scholars based in Italy, Switzerland and United States. Giuseppe Cancello's co-authors include Emilia Montagna, Marco Colleoni, Aron Goldhirsch, Paolo Veronesi, Alberto Luini, Giuseppe Viale, Giancarlo Pruneri, Nicole Rotmensz, Patrick Maisonneuve and Mauro G. Mastropasqua and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Giuseppe Cancello

42 papers receiving 2.0k citations

Peers

Countries citing papers authored by Giuseppe Cancello

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Cancello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Cancello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Cancello more than expected).

Fields of papers citing papers by Giuseppe Cancello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Cancello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Cancello. The network helps show where Giuseppe Cancello may publish in the future.

Co-authorship network of co-authors of Giuseppe Cancello

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Cancello. A scholar is included among the top collaborators of Giuseppe Cancello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Cancello. Giuseppe Cancello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 2020 ·Breast Cancer Research and Treatment ·Emilia Montagna, Eleonora Pagan, Vincenzo Bagnardi, Marco Colleoni, Giuseppe Cancello, Elisabetta Munzone, Silvia Dellapasqua, Nadia Bianco, (unknown), Monica Iorfida, Massimiliano Mazza, (unknown), Paolo Veronesi, Claudia Sangalli, (unknown), (unknown), Gabriella Pravettoni, Ketti Mazzocco, Viviana Galimberti	2
2	Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 2020 ·The Breast ·Emilia Montagna, Giuseppe Cancello, Eleonora Pagan, Vincenzo Bagnardi, Elisabetta Munzone, Silvia Dellapasqua, Giuseppe Viale, Giovanni Mazzarol, Paolo Veronesi, Viviana Galimberti, (unknown), Marco Colleoni	6
3	Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 2019 ·British Journal of Cancer ·Elisabetta Munzone, Vincenzo Bagnardi, (unknown), Ketti Mazzocco, Eleonora Pagan, A. Tramacere, Marianna Masiero, Monica Iorfida, Manuelita Mazza, Emilia Montagna, Giuseppe Cancello, Nadia Bianco, Antonella Palazzo, Anna Cardillo, Silvia Dellapasqua, Claudia Sangalli, (unknown), Gabriella Pravettoni, Marco Colleoni, Paolo Veronesi	33
4	Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy 2017 ·The Breast ·Emilia Montagna, Andrea Vingiani, Patrick Maisonneuve, Giuseppe Cancello, (unknown), Giancarlo Pruneri, Marco Colleoni	22
5	Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial 2017 ·Cancer Letters ·Emilia Montagna, Antonella Palazzo, Patrick Maisonneuve, Giuseppe Cancello, Monica Iorfida, Angela Sciandivasci, Angela Espósito, Anna Cardillo, Manuelita Mazza, Elisabetta Munzone, Antonella Lai, Aron Goldhirsch, Marco Colleoni	32
6	Metronomic therapy and breast cancer: A systematic review 2014 ·Cancer Treatment Reviews ·Emilia Montagna, Giuseppe Cancello, Silvia Dellapasqua, Elisabetta Munzone, Marco Colleoni	37
7	The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: Ready for prime time? 2013 ·Cancer Treatment Reviews ·Emilia Montagna, Giuseppe Cancello, Marco Colleoni	9
8	Pathological features and survival outcomes of very young patients with early breast cancer: How much is “very young”? 2013 ·The Breast ·Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, Emilia Montagna, Nicole Rotmensz, Giuseppe Viale, Giancarlo Pruneri, Paolo Veronesi, Alberto Luini, Oreste Gentilini, Aron Goldhirsch, Marco Colleoni	30
9	Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse 2012 ·Annals of Oncology ·Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Viale, Mauro G. Mastropasqua, Giancarlo Pruneri, Emilia Montagna, Monica Iorfida, Massimiliano Mazza, Alessandra Balduzzi, Paolo Veronesi, Alberto Luini, Mattia Intra, Aron Goldhirsch, Marco Colleoni	90
10	Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome 2012 ·Clinical Breast Cancer ·Emilia Montagna, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Cancello, Monica Iorfida, Alessandra Balduzzi, Viviana Galimberti, Paolo Veronesi, Alberto Luini, Giancarlo Pruneri, Luca Bottiglieri, Mauro G. Mastropasqua, Aron Goldhirsch, Giuseppe Viale, Marco Colleoni	114
11	Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity 2012 ·Clinical Breast Cancer ·Emilia Montagna, Giuseppe Cancello, Vincenzo Bagnardi, (unknown), Silvia Dellapasqua, (unknown), Giuseppe Viale, Paolo Veronesi, Alberto Luini, Mattia Intra, Angelica Calleri, Cristiano Rampinelli, Aron Goldhirsch, Francesco Bertolini, Marco Colleoni	57
12	Breast cancer subtypes and outcome after local and regional relapse 2011 ·Annals of Oncology ·Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, Giuseppe Viale, Giuseppe Renne, Giuseppe Cancello, Alessandra Balduzzi, Eloise Scarano, Paolo Veronesi, Alberto Luini, Stefano Zurrida, Simonetta Monti, Mauro G. Mastropasqua, Luca Bottiglieri, Aron Goldhirsch, Marco Colleoni	51
13	Outcome of special types of luminal breast cancer 2011 ·Annals of Oncology ·Marco Colleoni, Nicole Rotmensz, Patrick Maisonneuve, Mauro G. Mastropasqua, Alberto Luini, Paolo Veronesi, Mattia Intra, Emilia Montagna, Giuseppe Cancello, A. Cardillo, Massimiliano Mazza, (unknown), Monica Iorfida, Giancarlo Pruneri, Aron Goldhirsch, Giulia Viale	87
14	Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 2010 ·Annals of Oncology ·Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Viale, Mauro G. Mastropasqua, Giancarlo Pruneri, Paolo Veronesi, Rosalba Torrisi, Emilia Montagna, Alberto Luini, Mattia Intra, Oreste Gentilini, R. Ghisini, Aron Goldhirsch, Marco Colleoni	179
15	Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer 2010 ·Clinical Breast Cancer ·Rosalba Torrisi, Anna Cardillo, Giuseppe Cancello, Silvia Dellapasqua, Alessandra Balduzzi, R. Ghisini, Alberto Luini, Paolo Veronesi, Giuseppe Viale, Aron Goldhirsch, Marco Colleoni	21
16	Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. 2009 ·PubMed ·Andrea Rocca, Giuseppe Cancello, Vincenzo Bagnardi, Maria Teresa Sandri, Rosalba Torrisi, Laura Zorzino, Giuseppe Viale, Elisabetta Pietri, Paolo Veronesi, Silvia Dellapasqua, Pier Francesco Ferrucci, Alberto Luini, Harriet Johansson, R. Ghisini, Aron Goldhirsch, Marco Colleoni	14
17	Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure 2009 ·Breast Cancer Research and Treatment ·Emilia Montagna, Giuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, Viviana Galimberti, Alberto Luini, Mattia Intra, Paolo Veronesi, Giovanni Mazzarol, Giancarlo Pruneri, Giuseppe Renne, Rosalba Torrisi, A. Cardillo, Giuseppe Cancello, Aron Goldhirsch, Marco Colleoni	31
18	Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab 2008 ·Cancer Chemotherapy and Pharmacology ·Emilia Montagna, Giuseppe Cancello, Diana D’Agostino, Rossella Lauria, Valeria Forestieri, Alessandro Esposito, L Silvestro, Antonello Accurso, Sabino De Placido, Michelino De Laurentiis	27
19	Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer 2008 ·Breast Cancer Research ·Giuseppe Cancello, Emilia Montagna, Diego D’Agostino, Mario Giuliano, Antonio Giordano, Giuseppe Di Lorenzo, (unknown), Sabino De Placido, Michelino De Laurentiis	49
20	Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study 2007 ·European Urology ·Giuseppe Di Lorenzo, Riccardo Autorino, Sisto Perdonà, Michelino De Laurentiis, Massimo D’Armiento, Giuseppe Cancello, Vincenzo Mirone, Ciro Imbimbo, Nicola Longo, Vincenzo Altieri, Giampaolo Tortora, William D. Figg, Sabino De Placido	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact